The short version
6 companies supply this market — a reasonable cushion if one runs into trouble. Historically, drugs in this position went on to a new shortage within 90 days about 0.5% of the time — roughly 3× the typical drug (0.1%).
Market view
tobramycin · Injection, Powder, Lyophilized, For Solution
8 marketed package NDCs · 6 active manufacturers
Most dispensed: 300 mg/5mL · Solution · #14 pouchs/carton / 4 ampule in 1 pouch / 5 ml in 1 ampule · 300 mg/5mL · Solution · #56 ampules/carton / 5 ml in 1 ampule · 3 mg/mL · Solution/ Drops · #1 bottle/carton / 5 ml in 1 bottle · 3 mg/mL · Solution · #1 bottle, dropper/carton / 5 ml in 1 bottle, dropper
What changed in the last 90 days
Every detected change for tobramycin, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
- TobramycinAug 19, 2026Price downNADAC $1.09394 → $1.08452 per unit (-0.86%)
- TobramycinAug 19, 2026Price downNADAC $1.09394 → $1.08452 per unit (-0.86%)
- TobramycinAug 19, 2026Price downNADAC $1.09394 → $1.08452 per unit (-0.86%)
- TobramycinAug 19, 2026Price upNADAC $1.11758 → $1.15789 per unit (+3.61%)
- TobramycinAug 19, 2026Price downNADAC $1.09394 → $1.08452 per unit (-0.86%)
- TobramycinAug 19, 2026Price downNADAC $1.09394 → $1.08452 per unit (-0.86%)
- TobramycinAug 19, 2026Price upNADAC $0.65006 → $0.73949 per unit (+13.76%)
- TobramycinAug 19, 2026Price downNADAC $1.09394 → $1.08452 per unit (-0.86%)
- TobramycinAug 19, 2026Price upNADAC $1.11758 → $1.15789 per unit (+3.61%)
- TobramycinAug 19, 2026Price downNADAC $1.09394 → $1.08452 per unit (-0.86%)
Same drug class
Other molecules FDA puts in Aminoglycoside Antibacterial, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
- bacitracin· in shortage
- amikacin· 1 maker
- antibiotic pain relief· 1 maker
- bacitracin zin, neomycin sulfate, polymyxin b sulfate· 1 maker
- bacitracin zinc 400 u, polymxyin b sulfate 5,000 u, neomycin sulfate 3.5mg/g· 1 maker
- bacitracin zinc and neomycin and polymyxin b sulfate· 1 maker
- bacitracin zinc neomycin sulfate polymyxin b sulfate pramoxine hcl· 1 maker
- bacitracin zinc, neomycin and polymyxin b sulfate· 1 maker
- bacitracin zinc, neomycin sulfate , polymyxin b sulfate, lidocaine· 1 maker
- bacitracin zinc, neomycin sulfate and polymyxin b sulfate· 1 maker
- bacitracin zinc, neomycin sulfate, and polymyxin b· 1 maker
- bacitracin zinc, neomycin sulfate, polymyxin b· 1 maker
Common questions
- Is Tobramycin in shortage right now?
- No. FDA does not currently list Tobramycin in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Tobramycin?
- 45 companies have marketed Tobramycin in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
- What does Tobramycin cost?
- The typical pharmacy pays about $1.08 per mL, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.